Thus, the present study aimed to determine distribution of Cnt1-3 and Ent1-3 transcripts in 19 tissues of Sprague-Dawley rats and C57BL/6 mice of both genders. These six transcripts were quantified using the branched DNA signal amplification assay. Cnt1 transcripts were highest in small intestine, followed by kidney and testes, with similar expression in both species. Cnt2 mRNA was expressed highest in the small intestine of both rats and mice, intermediate in liver of rats but not in mice, and lower in thymus and spleen of both species. Cnt3 mRNA has marked species difference, with highest expression in lung of rats but uterus of mice. Ent1 mRNA was most highly expressed in testes and lung of both species. Ent1 mRNA was highly expressed in liver and pituitary of mice, but not in rats. Ent2 mRNA was highly expressed in testes and brain of both species. Ent3 mRNA was highest in kidney, followed by testes, in both species.
important 5-fluorouridine, 5-fluoro-2′-deoxyuridine, arabinosylcytosine, zidovudine (AZT), cladribine, diethyldithiocarbamate, 2',3'-dideoxyinosine, fludarabine, gemcitabine, melarsoprol, pentamidine, zalcitabine, and zebularine are substrates for nucleoside transporters (Hyde et al., 2001; Ritzel et al., 2001a; Damaraju et al., 2003; Gray et al., 2003) . Expression and activity of nucleoside transporters is an important determinant in disposition, efficacy, and toxicity of these nucleoside analogs in vivo (Damaraju et al., 2003) .
CNT1 is localized primarily in epithelia, such as intestine and kidney, whereas CNT2 and 3 have more broad distributions (Gray et al., 2003) . ENT1, 2, and 3 are all widely distributed in mammalian tissues, and ENT2 is particularly abundant in human skeletal muscle (Baldwin et al., 2003) . CNTs are located in the apical membrane, whereas ENTs are detected in the basolateral membrane of epithelial cells, suggesting a coordinate role of CNTs and ENTs in transepithelial nucleoside transport (Casado et al., 2002; Baldwin et al., 2003) .
Despite extensive functional characterization of human and rodent nucleoside transporters (for review see (Baldwin et al., 2003; Gray et al., 2003) , most knowledge on the tissue distribution of nucleoside transporters is obtained from humans, with little known about rats, and even less known about mice. Moreover, there are no published studies concerning gender-related differences in tissue distribution of nucleoside transporters, although gender differences in the disposition and toxicity of nucleoside analogs has been reported in humans (Burger et al., 1994; Pai and Nahata, 2000; Ofotokun and Pomeroy, 2003) .
In drug development, pharmacokinetics/toxicology (and frequently efficacy) studies in rats and mice are required before conducting clinical studies in humans. However, only ~36% of the site-specific carcinogenic effects observed in one species (rats or mice) were also detected in the other species (Haseman and Lockhart, 1993) . Many drug candidates fail in clinical trials due to undesirable This article has not been copyedited and formatted. The final version may differ from this version.
DMD Fast Forward. Published on September 15, 2004 as DOI: 10.1124 at ASPET Journals on April 28, 2017 dmd.aspetjournals.org Downloaded from ADME (absorption, distribution, metabolism and excretion) properties and toxicity (Lin et al., 2003) . In the development of anticancer and antiviral nucleoside and nucleobase drugs, it is very important to know not only the similarities, but also the differences in tissue distribution of these nucleoside transporters between humans, rats, and mice, as well as the differences between males and females, to correctly allow for extrapolation of animal data to humans.
The purpose of this study was to assemble comprehensive information on tissue distribution patterns of Cnt1, 2, 3 and Ent1, 2, 3 mRNA in rats and mice of both genders. The mRNA expression of these six nucleoside transporters in nineteen tissues of Sprague-Dawley rats and C57BL/6 mice was determined using the branched DNA (bDNA) signal amplification assay.
Our data showed that in general, tissue distribution of Cnts and Ents is similar in rats and mice;
however, a few important differences do exist. The similarities and differences between humans, rats, and mice, and the potential physiological importance of these observations are discussed. Branched DNA (bDNA) Signal Amplification Assay. Cnt1, 2, 3 and Ent1, 2, 3 mRNA was quantified using the bDNA assay (Quantigene TM bDNA signal amplification kit; Genospectra, Fremont, CA) with modifications (Leazer and Klaassen, 2003) . Sequences of target genes were accessed from GenBank. Multiple oligonucleotide probe sets (containing capture, label, and blocker probes) specific to a single mRNA transcript were designed using Probe Designer software v1.0 with a T m of approximately 63°C, enabling constant hybridization conditions (i.e., 53°C). Each probe developed in Probe Designer was submitted to the National Center for Biotechnology Information (NCBI, Bethesda, MD) for nucleotide comparison by the basic local alignment search tool (BLASTn) to ensure minimal cross-reactivity with other known rat/mouse sequences. Oligonucleotides with a high degree of similarity (>80%) to other rat or mouse gene transcripts were eliminated from the probe set design. The design of probe sets for rat Cnt1, 2 and Ent1, 2 was reported previously (Leazer and Klaassen, 2003) . The Genebank accession number, nucleotide sequence, and function for probes of mouse Cnt1-3, Ent1-3, and rat Cnt3 and Ent3 are given in mRNA is highly expressed in the three sections of small intestine, with duodenum and jejunum being the highest, and ileum much lower. Moderate levels of Cnt1 mRNA were also detected in kidney and testes of both species. Low expression of Cnt1 mRNA was found in brain of both species, heart of rats, stomach and prostate of mice, as well as female pituitary of mice. Cnt1 mRNA levels were very low in other tissues examined. Cnt1 mRNA in testes of rats and mice was 15-and 9-fold higher than that in ovary of rats and mice, respectively. Cnt2 mRNA was highly expressed in liver of rats but very low in liver of mice. In contrast to Cnt1 mRNA, which was expressed in only a few tissues, Cnt2 mRNA was expressed in many tissues, with the highest expression also in the small intestine, followed by spleen, thymus, heart, and lung of both species. Moderate to low expression of Cnt2 mRNA was found in all the other tissues examined. Mice had similar levels of Cnt2 mRNA in the three sections of small intestine, but rats had higher Cnt2 mRNA expression in duodenum than in jejunum and ileum. Female rats had ~60% higher Cnt2 mRNA in spleen and blood vessels than males. Rat and mouse testes had 74% and 3.1-fold higher Cnt2 mRNA than rat and mouse ovary, respectively. (Fig. 3) . In rats, Cnt3 mRNA was highest in lung with expression in males 87% higher than in females. In mice, Cnt3 mRNA was highest in uterus but low in lung. Moderate expression of Cnt3 was found in testes, prostate, ovary, brain, pituitary, and stomach of both species. In mice, Cnt3 mRNA was also moderately expressed in the three sections of small intestine with a higher expression in male jejunum, but Cnt3 mRNA was hardly detectable in duodenum and jejunum of rats. Cnt3 mRNA was moderately expressed in heart of rats but not detectable in heart of mice. Cnt3 mRNA in all the other tissues examined was very low. Rats had 2.3-fold higher Cnt3 mRNA in testes than in ovary, but mice tended to have lower Cnt3 mRNA in testes than in ovary. tissues examined. The highest Ent1 mRNA was found in testes of both species. Ent1 mRNA was also expressed at high to moderate levels in lung and liver of both species, but the lung to liver ratio was much higher in rats (~5.0) than in mice (0.5-0.7). Mice had high Ent1 mRNA in pituitary, but rats did not. Significant expression of Ent1 mRNA was detected in blood vessels of rats. Rats, but not mice, displayed significant male-predominant expression of Ent1 mRNA in heart, brain, and skeletal muscle. Female mice had 47% higher Ent1 mRNA expression in kidney than males. Rat and mouse testes had 18.3-and 2.8-fold higher Ent1 mRNA than rat and mouse ovary, respectively. ubiquitously expressed in all tissues examined. In both species, testes and brain were the two tissues with the highest expression of Ent2 mRNA, however, Ent2 mRNA was the highest in testes of rats, but highest in brain of mice. Rats, but not mice, displayed significant genderpredominant expression of Ent2 mRNA in spleen and blood vessels (63% and 83% higher in females than in males, respectively) as well as heart (67% higher in males than in females).
Materials and Methods

Animals
Tissue Distribution of Ent1 mRNA in Male and
Tissue Distribution of Ent2 mRNA in Male and
Female mice had 44% higher Ent2 mRNA expression in kidney than males. Rat and mouse testes had 9.3-and 1.1-fold higher Ent2 mRNA than rat and mouse ovary, respectively.
Tissue Distribution of Ent3 mRNA in Male and Female Rats and Mice. Tissue distribution
patterns of Ent3 mRNA are very similar between rats and mice ( Fig. 6 ). Similar to Ent1 and 2, Ent3 mRNA was also ubiquitously expressed. In both species, kidney had the highest expression of Ent3 mRNA, followed by testes. Rats exhibited significant male-predominant expression of Ent3 mRNA in lung, stomach, heart, and blood vessels (66, 90, 120, and 143% higher than This article has not been copyedited and formatted. The final version may differ from this version. females, respectively). Male mice had 65% higher Ent3 mRNA in kidney than females. Rat and mouse testes had 131% and 40% higher Ent3 mRNA than rat and mouse ovary, respectively.
Discussion
The present study demonstrates that in general, tissue distribution of Cnt and Ent is similar in rats and mice. However, a few marked species differences exist, such as with Cnt2 in liver (high in rats; low in mice), Cnt3 in lung (high in rats; low in mice), and Ent1 in pituitary (low in rats;
high in mice).
The mouse Cnt1 gene has not been identified in the published literature. However, a BLAST search of the Genebank with the rat Cnt1 gene sequence identified a similar cDNA clone (MGC:74379) from mouse kidney (Accession number BC061230). The deduced mouse Cnt1 protein contains 648 amino acids, the same length as rat Cnt1 protein, and shares 80% similarity with rat Cnt1 protein. Moreover, tissue distribution of Cnt1 mRNA (using probes against BC061230) in mice is very similar to that in rats (Fig. 1 ). These data indicate that sequence BC061230 is mouse Cnt1.
A considerable amount of Cnt1 protein has been detected in rat liver; however, using different methods, Cnt1 mRNA was either undetectable or detectable in rat liver (Huang et al., 1994; Felipe et al., 1998) . Therefore, Cnt1 mRNA may be expressed at low levels, and undergo significant post-transcriptional regulation in rat liver (Felipe et al., 1998 ). The present study
shows that Cnt1 mRNA in rat and mouse liver are very low. In contrast, Pennycooke et al.
reported a very high expression of CNT1 mRNA in human liver (Pennycooke et al., 2001 ).
Further study on protein expression is needed to draw conclusion on Cnt1 expression in mouse liver.
This article has not been copyedited and formatted. The final version may differ from this version. Cnt2 mRNA is highly expressed in the liver of rats but not in mice (Fig. 2) . In contrast, Ent1 mRNA is highly expressed in mouse liver (Fig. 4) , but only moderately expressed in rat liver (Fig. 4) . Both Cnt2 and Ent1 efficiently transport adenosine, but Cnt2 mediates concentrative and Na + -dependent, whereas Ent1 mediates bi-directional and Na + -independent transport.
Further study on adenosine uptake by mouse and rat liver may disclose the physiological significance of such a species-divergent expression of Cnt2 and Ent1 mRNA.
The present study demonstrates marked species differences in the tissue distribution of Cnt3 mRNA between rats and mice (Fig. 3) . The deduced rat Cnt3 and mouse Cnt3 protein share 86%
homology, and they are 72% homologous to human CNT3 protein. In humans, CNT3 transcripts are expressed at high levels in bone marrow, pancreas, trachea, mammary gland, and at moderate levels in lung, liver, testes, prostate, uterus and intestine (Ritzel et al., 2001b) . However, Cnt3 mRNA is not expressed in liver of rats or mice (Fig. 3) , and a separate study in this laboratory shows that Cnt3 is not expressed in bone marrow of rats (data not shown). Therefore, considerable species differences in tissue distribution of CNT3 exist between humans, mice, and rats. Human and mouse CNT3 efficiently transports both pyrimidine and purine anticancer nucleoside drugs (Ritzel et al., 2001b) . The marked species differences in CNT3 distribution may have profound impact on evaluating CNT3 substrates during drug development.
The tissue expression pattern of mouse Ent1 (Fig. 4) is generally consistent with a previous report (Choi et al., 2000) . Rat Ent1 and 2 have been functionally characterized, but their tissue distribution remained largely unknown (Yao et al., 1997; Yao et al., 2002) . In skeletal muscle, Ent1 and 2 are only moderately expressed in rats and mice ( Fig. 4 and 5) , which is different from the very abundant expression of ENT2 in humans (Baldwin et al., 2003 A preliminary report indicates that Ent3 has similar substrate specificity to Ent2, and may be predominantly localized to intracellular compartments (Baldwin et al., 2003) . The present study
shows that tissue expression patterns of Ent3 are very similar between rats and mice. The consistent high expression of Ent3 in kidney across species suggests that Ent3 may be important in the physiological functioning of kidney, probably facilitating the intracellular trafficking of nucleosides and nucleobases.
The present study demonstrates that Ent2 transcript is expressed at high levels, whereas Cnt1
and Cnt2 transcripts are at low levels in the brain (Fig. 1, 2, 5 ). In contrast, in choroid plexus, which locates in the ventricles of the brain, Ent2 is expressed at low levels, whereas Cnt1 and Gender differences in expression patterns of transporters may have profound effects on basal physiology as well as drug efficacy and toxicity. The present study provides the first evidence of significant gender differences in expression of various nucleoside transporters in rats and mice.
An intriguing observation is the gender-divergent expression of Ents in mouse kidney; males have lower expression of Ent1 (Fig. 4) and Ent2 (Fig. 5 ), but higher expression of Ent3 (Fig. 6) than females. In humans, adenine phosphoribosyltransferase deficiency causes a defect in AMP synthesis from adenine; as a result, adenine is oxidized to poorly water-soluble 2,8-dihydroxyadenine, which precipitates in the urine or kidney, causing nephrolithiasis and chronic renal failure. Interestingly, in an adenine phosphoribosyltransferase-null mouse model of nephrolithiasis, males have more pronounced kidney damage than females (Stockelman et al., 1998) . The observed gender-divergent expression of Ents, and the resultant gender-difference in renal excretion and metabolism of adenine could be a major molecular mechanism underlying such a gender difference.
The present study shows that in heart, male and female rats express similar levels of Cnt1, 2, and 3 transcripts, but females have significantly lower levels of Ent1, 2, and 3 transcripts than males. In both humans and rats, males are known to be more vulnerable to cardiovascular diseases than females. Adenosine exerts its potent cardiovascular protective effect through inhibitor-sensitive nucleoside transporters (ENTs) may function as an efflux barrier to prevent intravascular adenosine into the interstitium of heart or blood vessels (Gamboa et al., 2003) .
Currently, there is no report regarding gender-related information on expression of nucleoside transporters in human heart. Should women have lower expression of ENTs in heart (as observed in rats), this may result in a better uptake of adenosine, and thus a significantly higher basal myocardial blood flow (Chareonthaitawee et al., 2001 ) and better protection against certain cardiovascular diseases than men. Interestingly, the present study also demonstrates significant gender differences in expression of Cnt2, Ent2, and Ent3 in blood vessels of rats. Further study on the putative gender differences in expression of ENTs and/or CNTs in the cardiovascular tissues of humans is warranted.
The present study shows that multiple Cnts and Ents are expressed in the sex tissues of rats and mice, such as testes, prostate, ovary, and uterus. Importantly, the considerable expression of all six types of nucleoside transporters in testes may contribute to the high sensitivity of testicular cancer to chemotherapy (Chaganti and Houldsworth, 2000) and the vulnerability of testes to nucleoside drug-induced toxicity. Moreover, previous study demonstrates that Cnt2, Ent1, and Ent2 transcripts are expressed in placenta at levels comparable to liver/kidney (Leazer and Klaassen, 2003) . Thus, effects of nucleosides and nucleoside analogs on male and female reproduction necessitate scrutiny.
In conclusion, nucleoside transporters have essential physiological functions, and they are important in the disposition of anticancer and antiviral nucleoside analogs (Damaraju et al., 2003) . The present study provides the most complete information to date on mRNA tissue expression patterns of all known Cnts and Ents in rats and mice. The observed species and gender differences could be responsible for some species and gender differences in disposition, This article has not been copyedited and formatted. The final version may differ from this version. efficacy, and toxicity of endobiotics and xenobiotics that are substrates for these transporters.
Such knowledge is crucial for understanding the similarities and differences between humans and experimental animals regarding drug development and carcinogenesis. This article has not been copyedited and formatted. The final version may differ from this version. 
